L. V. Stakhovskaya

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)

L. V. Stakhovskaya, N. А. Shamalov, A S Agafiina et al. · S S Korsakov Journal of Neurology and Psychiatry · 2017 · 65 citations

Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news

I. Yu. Torshin, L. V. Stakhovskaya, A.N. Galustyan et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 2020 · 25 citations · Full text

Analysis of epidemiological indicators of recurrent stroke in regions of Russian Federation (On the basis of territorial and population registry 2009–2014)

L. V. Stakhovskaya, Olga Klochikhina, Madina Bogatyreva · Consilium Medicum · 2016 · 22 citations · Full text

Stroke Rehabilitation, Russian Federation, Cardiovascular Disease +11

An analysis of the dynamics of the main types of stroke and pathogenetic variants of ischemic stroke

N. А. Shamalov, L. V. Stakhovskaya, O A Klochihina · S S Korsakov Journal of Neurology and Psychiatry · 2019 · 22 citations